PRMT5 and hepatocellular carcinoma: PRMT5 mRNA was significantly overexpressed in all stages of HCC relative to its normal counterpart; it was very highly elevated in stages II (p < 0.05) and III (p < 0.01) relative to stage I (Figure 1c).